Treatment options for HRS type-1 are limited and prior data for terlipressin was mixed. This RCT tried to shed further light on the efficacy of terlipressin.
Lizzie Aby is currently a second-year gastroenterology and hepatology fellow at the University of Minnesota. Lizzie is originally from Minneapolis, but completed her internal medicine residency training and chief residency at UCLA. She was an American Association for the Study of Liver Diseases (AASLD) Emerging Liver Scholar in 2016 and was subsequently an ambassador from 2017 to 2019.
View all posts by Lizzie Aby
